ArticleFrontiers in radiology2026
Development and validation of a nomogram using interpretable machine learning to integrate CT radiomics and PET metabolic parameters for predicting benign-malignant differentiation of pulmonary space-occupying lesions.
Article in Frontiers in radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To construct a multimodal machine learning model integrating computed tomography (CT) radiomics, Positron Emission Tomography (PET) metabolic parameters, and clinical data for differentiating benign from malignant pulmonary space-occupying lesions (PSOLs), and develop an interpretable nomogram for clinical application. Methodology: This study enrolled 384 patients with PSOLs who underwent dual-time-point Results: A Rad-score was constructed from 17 optimally selected features. In the independent temporal validation set, the single-modality models achieved AUCs of 0.808 (Radiomics Model), 0.732 (Clinical Model), and 0.874 (Metabolic Model). Among all tested models, the XGBoost integrated model achieved the highest AUC of 0.967, which was significantly higher than that of all other models (Bonferroni-adjusted Conclusions: The predictive logic of the optimal XGBoost model was decoded via SHAP analysis to identify core predictive features, and a clinically applicable, interpretable nomogram was further established based on a multivariate logistic regression model using these core features, to facilitate the clinical translation of our model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.